Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells
- PMID: 31120636
- PMCID: PMC6558470
- DOI: 10.1111/1759-7714.13096
Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells
Abstract
Background: No effective treatment is currently available for poorly differentiated thyroid cancer which is resistant to radioiodine, especially with migration and invasion. A great number of researches have revealed the anticancer effects of salidroside, but none have studied the effects of salidroside on thyroid cancer. This study aimed to investigate the effect of salidroside on migration and invasion of poorly differentiated thyroid cancer cells.
Methods: The effects of salidroside on migration, invasion and apoptosis of poorly differentiated thyroid cancer WRO cells and normal thyroid follicular epithelial Nthy-ori 3-1 cells were measured by wound-healing assay, transwell migration/invasion assay and flow cytometry, respectively. The expression levels of MMP2 and MMP9 at RNA and protein levels in WRO cells were detected by qRT-PCR and western blot. The phosphorylation levels of Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3) and the apoptosis-related protein levels of Bax, cleaved caspase 3 and Bcl-2 were assessed by western blot.
Results: Salidroside significantly suppressed migration/invasion and induced apoptosis in poorly differentiated thyroid cancer WRO cells. We further illustrated that salidroside significantly inhibited expressions of MMP2 and MMP9 at mRNA and protein levels and the phosphorylation activation of JAK2/STAT3 in WRO cells. In addition, salidroside increased expressions of pro-apoptotic factors (Bax and cleaved caspase 3) and decreased expression of anti-apoptotic factor (Bcl-2) significantly in WRO cells.
Conclusion: The present study demonstrates that salidroside inhibits migration and invasion of WRO cells (a kind of poorly differentiated cancer cell line) significantly, which might be via suppressing JAK2-STAT3 signaling pathway.
Keywords: Invasion; migration; poorly differentiated thyroid cancer; salidroside.
© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Figures
Similar articles
-
Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.Int J Oncol. 2018 Aug;53(2):877-885. doi: 10.3892/ijo.2018.4430. Epub 2018 Jun 5. Int J Oncol. 2018. PMID: 29901185
-
Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.Int J Oncol. 2019 Jun;54(6):1969-1980. doi: 10.3892/ijo.2019.4781. Epub 2019 Apr 10. Int J Oncol. 2019. PMID: 31081055 Free PMC article.
-
Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway.Int J Clin Exp Pathol. 2015 Jan 1;8(1):615-21. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25755753 Free PMC article.
-
Salidroside inhibits the proliferation and migration of gastric cancer cells via suppression of Src‑associated signaling pathway activation and heat shock protein 70 expression.Mol Med Rep. 2018 Jul;18(1):147-156. doi: 10.3892/mmr.2018.8958. Epub 2018 May 3. Mol Med Rep. 2018. PMID: 29749547 Free PMC article.
-
Selenomethionine Suppress the Progression of Poorly Differentiated Thyroid Cancer via LncRNA NONMMUT014201/miR-6963-5p/Srprb Pathway.Comb Chem High Throughput Screen. 2024;27(16):2419-2432. doi: 10.2174/0113862073286006231228070738. Comb Chem High Throughput Screen. 2024. PMID: 38173060
Cited by
-
Investigating the multitarget pharmacological mechanism of Rhodiola wallichiana var. cholaensis acting on angina pectoris using combined network pharmacology and molecular docking.J Thorac Dis. 2024 Feb 29;16(2):1350-1367. doi: 10.21037/jtd-23-1891. Epub 2024 Feb 22. J Thorac Dis. 2024. PMID: 38505080 Free PMC article.
-
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.Oncol Lett. 2020 Nov;20(5):240. doi: 10.3892/ol.2020.12103. Epub 2020 Sep 15. Oncol Lett. 2020. PMID: 32973954 Free PMC article.
-
Fabrication and characterization of salidroside W/O/W emulsion with sodium alginate.Food Chem X. 2024 Feb 29;22:101260. doi: 10.1016/j.fochx.2024.101260. eCollection 2024 Jun 30. Food Chem X. 2024. PMID: 38450386 Free PMC article.
-
Mechanism of salidroside in tumor suppression through the miRNA-mRNA signaling axis.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):810-817. doi: 10.11817/j.issn.1672-7347.2024.230480. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39174895 Free PMC article. Review. Chinese, English.
-
Salidroside inhibits chronic myeloid leukemia cell proliferation and induces apoptosis by regulating the miR-140-5p/wnt5a/β-catenin axis.Exp Ther Med. 2021 Nov;22(5):1249. doi: 10.3892/etm.2021.10684. Epub 2021 Sep 2. Exp Ther Med. 2021. PMID: 34539845 Free PMC article.
References
-
- Volante M, Landolfi S, Chiusa L et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: A clinicopathologic study of 183 patients. Cancer 2004; 100: 950–7. - PubMed
-
- Rossi ED, Straccia P, Palumbo M et al. Diagnostic and prognostic role of HBME‐1, galectin‐3, and β‐catenin in poorly differentiated and anaplastic thyroid carcinomas. Appl Immunohistochem Mol Morphol 2013; 21: 237–41. - PubMed
-
- Burman KD. Is poorly differentiated thyroid cancer poorly characterized? J Clin Endocrinol Metab 2014; 99: 1167–9. - PubMed
-
- Paterson I, Anderson EA. Chemistry. The renaissance of natural products as drug candidates. Science 2005; 310: 451–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous